ConductScience.org, home

Paper16404366

Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.

Went P and 9 others. Br J Cancer, 2006. Cited by 319 papers, by iCite.

Cite this record

ConductScience Library. Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers. Papers, record 16404366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16404366

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.
PubMed
Journal
Br J Cancer
PubMed
Year
2006
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
319
iCite
Relative citation ratio, by iCite
6.64
iCite
Revised in PubMed
2024-07-26
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Went PP
2Vasei MM
3Bubendorf LL
4Terracciano LL
5Tornillo LL
6Riede UU
7Kononen JJ
8Simon RR
9Sauter GG
10Baeuerle PAP A

Source PubMed

Download CSV of authors

Topics23

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antigens, NeoplasmMajor topic
Cell Adhesion MoleculesMajor topic
Colonic NeoplasmsMajor topic
Lung NeoplasmsMajor topic
Neoplasm StagingMajor topic
Prostatic NeoplasmsMajor topic
Stomach NeoplasmsMajor topic
Adult
Aged
Aged, 80 and over
Biomarkers, Tumor
Epithelial Cell Adhesion Molecule
Female
Gene Expression Profiling
Humans
Immunohistochemistry
Immunotherapy
Male
Middle Aged
Prognosis
Protein Array Analysis
Retrospective Studies
Survival Analysis

Source PubMed

Download CSV of topics

References59

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110821496The expression of Ep-CAM (17-1A) in squamous cell cancers of the lung.Hum Pathol2000https://conductscience.org/library/papers/10821496PubMed
215655555Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines.Br J Cancer2005https://conductscience.org/library/papers/15655555PubMed
312241873Edrecolomab alone or in combination with fluorouracil and folinic acid in the adjuvant treatment of stage III colon cancer: a randomised study.Lancet2002https://conductscience.org/library/papers/12241873PubMed
415756257Adenoviral vector-mediated expression of a gene encoding secreted, EpCAM-targeted carboxylesterase-2 sensitises colon cancer spheroids to CPT-11.Br J Cancer2005https://conductscience.org/library/papers/15756257PubMed
59563756Reduced E-cadherin expression is associated with increased lymph node metastasis and unfavorable prognosis in non-small cell lung cancer.Am J Respir Crit Care Med1998https://conductscience.org/library/papers/9563756PubMed
616139892MT110: a novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors.Mol Immunol2006https://conductscience.org/library/papers/16139892PubMed
711960289Inhibition of tumor growth by recombinant vaccinia virus expressing GA733/CO17-1A/EpCAM/KSA/KS1-4 antigen in mice.Cancer Gene Ther2002https://conductscience.org/library/papers/11960289PubMed
811358833The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapy.Cancer Res2001https://conductscience.org/library/papers/11358833PubMed
97909866Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group.Lancet1994https://conductscience.org/library/papers/7909866PubMed
1015472903Expression patterns of potential therapeutic targets in prostate cancer.Int J Cancer2005https://conductscience.org/library/papers/15472903PubMed
1111568893Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies.J Pathol2001https://conductscience.org/library/papers/11568893PubMed
122210778Production of a monoclonal antibody (K 931) to a squamous cell carcinoma associated antigen identified as the 17-1A antigen.Hybridoma1990https://conductscience.org/library/papers/2210778PubMed
1314581349Identification of epithelial cell adhesion molecule autoantibody in patients with ovarian cancer.Clin Cancer Res2003https://conductscience.org/library/papers/14581349PubMed
1414633587The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology.Am J Pathol2003https://conductscience.org/library/papers/14633587PubMed
1515933423Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III study.Onkologie2005https://conductscience.org/library/papers/15933423PubMed
1611709702Identification of genes involved in epithelial-mesenchymal transition and tumor progression.Oncogene2001https://conductscience.org/library/papers/11709702PubMed
1715805290Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-/CD3-bispecific antibody construct.Cancer Res2005https://conductscience.org/library/papers/15805290PubMed
1815870832Loss of Ep-CAM (CO17-1A) expression predicts survival in patients with gastric cancer.Br J Cancer2005https://conductscience.org/library/papers/15870832PubMed
1910655996Expression of the 17-1A antigen in gastric and gastro-oesophageal junction adenocarcinomas: a potential immunotherapeutic target?J Clin Pathol1999https://conductscience.org/library/papers/10655996PubMed
2015195135The carcinoma-associated antigen EpCAM upregulates c-myc and induces cell proliferation.Oncogene2004https://conductscience.org/library/papers/15195135PubMed

See all 59 referencesDownload CSV of references

Cited by190

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 319 citations.

PMIDTitleJournalYearIn PapersSource
42834750Targeting the EpCAM-AXL axis to overcome drug resistance in lung cancer.Mol Oncol2026https://conductscience.org/library/papers/42834750PubMed
42540187Development and Preclinical Evaluation of a Novel EpCAM-Targeted 111In-Labeled Antibody for SPECT Imaging.ACS Omega2026https://conductscience.org/library/papers/42540187PubMed
42380103Wnt signaling-mediated activation of cancer cell stemness in thoracic SMARCA4-deficient undifferentiated tumor cells.Cell Death Discov2026https://conductscience.org/library/papers/42380103PubMed
41989931Docetaxel-Induced Immune Activation Shows Antitumor Synergy With the Tumor-Targeted CD40 Agonist KK2269.Cancer Sci2026https://conductscience.org/library/papers/41989931PubMed
41785279EpCAM silencing suppresses aggressive phenotypes and induces partial redifferentiation in anaplastic thyroid cancer cells.PLoS One2026https://conductscience.org/library/papers/41785279PubMed
41717407Advancing CAR-T therapy in prostate cancer: overcoming the tumor microenvironment and enhancing efficacy.Front Oncol2026https://conductscience.org/library/papers/41717407PubMed
41711582Accessing the DNA in Breast Tissue: Adhesive Cell Capture from Flow onto Fibers of Cellulose Papers.ACS Appl Mater Interfaces2026https://conductscience.org/library/papers/41711582PubMed
41674973Therapeutic application of IL-12 for cancer therapy.Transl Cancer Res2026https://conductscience.org/library/papers/41674973PubMed
41649879The TRAP complex (SSR1-SSR4): mechanistic roles and therapeutic opportunities.Ann Med2026https://conductscience.org/library/papers/41649879PubMed
41275209Development and clinical trial of M701, an Anti-EpCAM × Anti-CD3 bispecific antibody: a targeted intraperitoneal therapy for malignant ascites stemming from advanced solid tumors.Exp Hematol Oncol2025https://conductscience.org/library/papers/41275209PubMed
41233827Advances in PLGA-based polymeric nanocarriers for colorectal cancer therapy: overcoming chemoresistance through controlled delivery strategies.Mol Cancer2025https://conductscience.org/library/papers/41233827PubMed
40927663Emerging Applications of EpCAM-Targeted Nuclear Medicine Probes: Current Research and Future Perspectives.Int J Nanomedicine2025https://conductscience.org/library/papers/40927663PubMed
40563608Impact of Neoadjuvant Treatment on Target Expression in Rectal Cancer for Near-Infrared Tumor Imaging.Cancers (Basel)2025https://conductscience.org/library/papers/40563608PubMed
40445498Selection of the optimal chelator for labeling of DARPin Ec1 with gallium-68 for PET imaging of EpCAM expression.EJNMMI Radiopharm Chem2025https://conductscience.org/library/papers/40445498PubMed
40277763Unveiling the Synergistic Potential: Bispecific Antibodies in Conjunction with Chemotherapy for Advanced Non-Small-Cell Lung Cancer Treatment.Curr Oncol2025https://conductscience.org/library/papers/40277763PubMed
40037156Contemporary Management of Malignant Ascites.J Surg Res2025https://conductscience.org/library/papers/40037156PubMed
39724301Modification of Fc-fusion protein structures to enhance efficacy of cancer vaccine in plant expression system.Plant Biotechnol J2025https://conductscience.org/library/papers/39724301PubMed
39172329Clinical Progresses and Challenges of Bispecific Antibodies for the Treatment of Solid Tumors.Mol Diagn Ther2024https://conductscience.org/library/papers/39172329PubMed
38791091Regulation of the Function and Expression of EpCAM.Biomedicines2024https://conductscience.org/library/papers/38791091PubMed
38627681Efficacy and safety of bispecific antibodies vs. immune checkpoint blockade combination therapy in cancer: a real-world comparison.Mol Cancer2024https://conductscience.org/library/papers/38627681PubMed

See all 190 cited byDownload CSV of cited by

Genes10

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16404366

GET https://conductscience.org/api/papers/v1/16404366/references?page=2